Inherited variants in CHD3 show variable expressivity in Snijders Blok-Campeau syndrome.


Journal

Genetics in medicine : official journal of the American College of Medical Genetics
ISSN: 1530-0366
Titre abrégé: Genet Med
Pays: United States
ID NLM: 9815831

Informations de publication

Date de publication:
06 2022
Historique:
received: 18 10 2021
revised: 22 02 2022
accepted: 22 02 2022
pubmed: 30 3 2022
medline: 3 6 2022
entrez: 29 3 2022
Statut: ppublish

Résumé

Common diagnostic next-generation sequencing strategies are not optimized to identify inherited variants in genes associated with dominant neurodevelopmental disorders as causal when the transmitting parent is clinically unaffected, leaving a significant number of cases with neurodevelopmental disorders undiagnosed. We characterized 21 families with inherited heterozygous missense or protein-truncating variants in CHD3, a gene in which de novo variants cause Snijders Blok-Campeau syndrome. Computational facial and Human Phenotype Ontology-based comparisons showed that the phenotype of probands with inherited CHD3 variants overlaps with the phenotype previously associated with de novo CHD3 variants, whereas heterozygote parents are mildly or not affected, suggesting variable expressivity. In addition, similarly reduced expression levels of CHD3 protein in cells of an affected proband and of healthy family members with a CHD3 protein-truncating variant suggested that compensation of expression from the wild-type allele is unlikely to be an underlying mechanism. Notably, most inherited CHD3 variants were maternally transmitted. Our results point to a significant role of inherited variation in Snijders Blok-Campeau syndrome, a finding that is critical for correct variant interpretation and genetic counseling and warrants further investigation toward understanding the broader contributions of such variation to the landscape of human disease.

Identifiants

pubmed: 35346573
pii: S1098-3600(22)00672-4
doi: 10.1016/j.gim.2022.02.014
pii:
doi:

Substances chimiques

Mi-2 Nucleosome Remodeling and Deacetylase Complex EC 3.5.1.98
DNA Helicases EC 3.6.4.-
CHD3 protein, human EC 3.6.4.12

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1283-1296

Subventions

Organisme : Medical Research Council
ID : MC_PC_17228
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_QA137853
Pays : United Kingdom
Organisme : NHGRI NIH HHS
ID : R01 HG009141
Pays : United States
Organisme : NHGRI NIH HHS
ID : UM1 HG008900
Pays : United States

Informations de copyright

Copyright © 2022 American College of Medical Genetics and Genomics. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of Interest M.L.T. is an employee of HudsonAlpha Institute for Biotechnology. For D.M., the following statements are applicable: “Research disclaimer: The views expressed in this article reflect the results of research conducted by the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, or the United States Government. Copyright statement: I am a military service member. This work was prepared as part of my official duties. Title 17 U.S.C. 105 provides that "Copyright protection under this title is not available for any work of the United States Government." Title 17 U.S.C. 101 defines a United States Government work as a work prepared by a military service member or employee of the United States Government as part of that person’s official duties.” All other authors declare no conflicts of interest.

Auteurs

Jet van der Spek (J)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands; Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.

Joery den Hoed (J)

Department of Language and Genetics, Max Planck Institute for Psycholinguistics, Nijmegen, The Netherlands; International Max Planck Research School for Language Sciences, Max Planck Institute for Psycholinguistics, Nijmegen, The Netherlands.

Lot Snijders Blok (L)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands; Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Language and Genetics, Max Planck Institute for Psycholinguistics, Nijmegen, The Netherlands.

Alexander J M Dingemans (AJM)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands; Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.

Dick Schijven (D)

Department of Language and Genetics, Max Planck Institute for Psycholinguistics, Nijmegen, The Netherlands.

Christoffer Nellaker (C)

Nuffield Department of Women's and Reproductive Health, University of Oxford, Women's Centre, John Radcliffe Hospital, Oxford, United Kingdom; Department of Engineering Science, Institute of Biomedical Engineering, University of Oxford, Oxford, United Kingdom; Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, United Kingdom.

Hanka Venselaar (H)

Center for Molecular and Biomolecular Informatics, Radboud University Medical Center, Nijmegen, The Netherlands.

Galuh D N Astuti (GDN)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands; Division of Human Genetics, Center for Biomedical Research (CEBIOR), Faculty of Medicine, Diponegoro University, Semarang, Indonesia.

Tahsin Stefan Barakat (TS)

Department of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

E Martina Bebin (EM)

Department of Neurology, University of Alabama at Birmingham, Birmingham, AL.

Stefanie Beck-Wödl (S)

Department of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.

Gea Beunders (G)

Department of Genetics, University Medical Center Groningen, Groningen, The Netherlands.

Natasha J Brown (NJ)

Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Parkville, Victoria, Australia; Department of Pediatrics, University of Melbourne, Royal Children's Hospital, Parkville, Victoria, Australia.

Theresa Brunet (T)

Institute of Human Genetics, School of Medicine, Technical University Munich, Munich, Germany.

Han G Brunner (HG)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands; Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Clinical Genetics, Maastricht University Medical Center, GROW School for Oncology and Developmental Biology, and MHeNS School for Mental health and Neuroscience, Maastricht University, Maastricht, The Netherlands.

Philippe M Campeau (PM)

CHU Sainte-Justine Research Center, Montreal, Quebec, Canada; Sainte-Justine Hospital, University of Montreal, Montreal, Quebec, Canada.

Goran Čuturilo (G)

University Children's Hospital Belgrade, Belgrade, Serbia; Faculty of Medicine, University of Belgrade, Belgrade, Serbia.

Christian Gilissen (C)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.

Tobias B Haack (TB)

Department of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.

Irina Hüning (I)

Institute of Human Genetics, University of Lübeck, Lübeck, Germany.

Ralf A Husain (RA)

Department of Neuropediatrics, Jena University Hospital, Jena, Germany.

Benjamin Kamien (B)

Genetic Services of Western Australia, King Edward Memorial Hospital, Perth, Western Australia, Australia.

Sze Chern Lim (SC)

Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Parkville, Victoria, Australia.

Luca Lovrecic (L)

Clinical Institute for Genomic Medicine, University Medical Center Ljubljana, Ljubljana, Slovenia.

Janine Magg (J)

Department of Neuropaediatrics, Developmental Neurology, Social Pediatrics, University Children's Hospital, University of Tübingen, Tübingen, Germany.

Ales Maver (A)

Clinical Institute for Genomic Medicine, University Medical Center Ljubljana, Ljubljana, Slovenia.

Valancy Miranda (V)

CHU Sainte-Justine Research Center, Montreal, Quebec, Canada; Sainte-Justine Hospital, University of Montreal, Montreal, Quebec, Canada.

Danielle C Monteil (DC)

Department of Pediatrics, Naval Medical Center Portsmouth, Portsmouth, VA.

Charlotte W Ockeloen (CW)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.

Lynn S Pais (LS)

Broad Institute Center for Mendelian Genomics, Broad Institute of MIT and Harvard, Cambridge, MA.

Vasilica Plaiasu (V)

INSMC Alessandrescu-Rusescu, Regional Center of Medical Genetics Bucharest, Bucharest, Romania.

Laura Raiti (L)

Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Parkville, Victoria, Australia.

Christopher Richmond (C)

Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Parkville, Victoria, Australia; Genetic Health Queensland, Royal Brisbane and Women's hospital, Herston, Queensland, Australia; School of Medicine, Griffith University, Southport, Queensland, Australia.

Angelika Rieß (A)

Department of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.

Eva M C Schwaibold (EMC)

Institute of Human Genetics, Heidelberg University, Heidelberg, Germany.

Marleen E H Simon (MEH)

Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.

Stephanie Spranger (S)

Praxis für Humangenetik-Bremen, Bremen, Germany.

Tiong Yang Tan (TY)

Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Parkville, Victoria, Australia; Department of Pediatrics, University of Melbourne, Royal Children's Hospital, Parkville, Victoria, Australia.

Michelle L Thompson (ML)

HudsonAlpha Institute for Biotechnology, Huntsville, AL.

Bert B A de Vries (BBA)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands; Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.

Ella J Wilkins (EJ)

Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Parkville, Victoria, Australia.

Marjolein H Willemsen (MH)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.

Clyde Francks (C)

Department of Language and Genetics, Max Planck Institute for Psycholinguistics, Nijmegen, The Netherlands; Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, Netherlands.

Lisenka E L M Vissers (LELM)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands; Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.

Simon E Fisher (SE)

Department of Language and Genetics, Max Planck Institute for Psycholinguistics, Nijmegen, The Netherlands; Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, Netherlands.

Tjitske Kleefstra (T)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands; Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands; Center of Excellence for Neuropsychiatry, Vincent van Gogh Institute for Psychiatry, Venray, The Netherlands. Electronic address: Tjitske.Kleefstra@radboudumc.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH